Table 1.
Characteristic | Candidate gene studies | ISC |
---|---|---|
| ||
Studies | 1,375 | - |
| ||
Genes (autosomal) | 732 | - |
| ||
Markers (autosomal) | ||
Total | 6,934 | 1,948,385 |
Markers per gene, median (IQR) | 2 (1–5) | 9 (1–34) |
Genes with 1, 2, or 3 markers | 65.9% | n/a |
Marker density per gene as kb/SNP, median (IQR) | 15.4 (4.69–46.2) | 1.38 (0.69–2.47) |
| ||
Sample size | Median (range) a | Actual |
Total subjects | 412 (27–5,623) | 6,909 |
Number of cases | 191 (5–2,434) | 3,322 |
Number of controls | 214 (12–4,899) | 3,587 |
| ||
Major annotation clusters from pathway analysis | Enrichment score | |
Synaptic transmission | 52.2 | n/a |
Neuronal development and morphogenesis | 32.4 | |
Regulation of synaptic transmission | 22.6 | |
Response to chemical stimuli | 22.2 | |
| ||
Statistical power b | 0.48 | 0.89 |
| ||
Proportion of autosomal RefSeq genes studied c | 0.037 | 0.902 |
| ||
Proportion of genes in top 4 DAVID annotation clusters studied | 0.067 | n/a |
Biased due to subject overlap across publications.
See text for assumptions.
For ISC, assuming gene boundaries expanded by ±10 kb and SNP density < 20 kb/SNP.
IQR=inter-quartile range. FDR=false discovery rate. GRR=genotypic relative risk. MAF=minor allele frequency.